Meeting Highlights

Vaginal mesh vs native tissue repairs for prolapse: FDA update and recent evidence

Author: Catherine S. Bradley (University of Iowa)

  • Vaginal mesh vs native tissue repairs for prolapse: FDA update and recent evidence

    Meeting Highlights

    Vaginal mesh vs native tissue repairs for prolapse: FDA update and recent evidence

    Author:

Abstract

In 2010, 300,000 surgeries were performed in the U.S. for pelvic organ prolapse (POP), and 100,000 of those involved the placement of surgical mesh. The use of mesh in abdominal surgeries for POP has been described for over 50 years, but the first surgical mesh product specifically for POP was approved by the FDA in 2002. Over the last decade, transvaginal mesh POP surgeries have become more common, and mesh “kits” have been approved and are increasingly used for transvaginal POP repair, but clinical trial evidence of their safety and effectiveness has lagged behind rapid adoption into practice.

Keywords: prolapse, vaginal mesh, transvaginal repair

How to Cite:

Bradley, C. S., (2011) “Vaginal mesh vs native tissue repairs for prolapse: FDA update and recent evidence”, Proceedings in Obstetrics and Gynecology 2(2), 1-2. doi: https://doi.org/10.17077/2154-4751.1125

Rights: Copyright © Catherine S. Bradley, 2011.

Downloads:
Download pdf
View PDF

325 Views

1042 Downloads

Published on
15 Nov 2011
Peer Reviewed
License
CC BY 3.0